Key result
Walking is consistently associated with reduced cardiovascular disease endpoints and improvements in clinical biomarkers, supporting its role in primary and secondary prevention.
Why the study?
Does walking improve cardiovascular disease endpoints and clinical biomarkers in the general population?
Does walking improve cardiovascular disease endpoints and clinical biomarkers in the general population?
Walking is an accessible, low-risk physical activity that provides significant cardiovascular health benefits and can be effectively promoted in clinical practice.
No takes yet. Share an insight, caveat, or question.
May support promoting walking for CVD prevention in practice; leaves open causality pending randomized trials.
Murtagh et al. (2010) conducted a review in Cardiovascular disease. Walking was evaluated on Cardiovascular disease endpoints and clinical biomarkers. Walking is consistently associated with reduced cardiovascular disease endpoints and improvements in clinical biomarkers, supporting its role in primary and secondary prevention.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: